Active Biotech: Notice of Annual General Meeting of Shareholders
April 26 2016 - 2:36AM
The Board of Directors of Active Biotech AB (publ) has issued a
notice to the Annual General Meeting, which is to take place on
Thursday, May 26, 2016, at 5 pm at Elite Hotel Ideon, Scheelevägen
27 in Lund, Sweden.
Please see the attached notification, which is
being announced within short in Svenska Dagbladet and Post- och
Inrikes Tidningar.
Lund, April 26, 2016 ACTIVE BIOTECH AB (PUBL)
THE BOARD OF DIRECTORS
Active Biotech AB (publ) (Nasdaq
Stockholm: ACTI) is a biotechnology company with focus on
neurodegenerative/inflammatory diseases and cancer. Laquinimod, an
orally administered small molecule with unique immunomodulatory
properties, is in pivotal Phase 3 development for the treatment of
relapsing remitting multiple sclerosis. Also, laquinimod is in
Phase 2 development for the treatment of primary progressive
multiple sclerosis and Huntington's disease. Furthermore,
commercial activities are conducted for the ISI, ANYARA and
paquinimod projects. Please visit www.activebiotech.com for more
information.
Active Biotech AB PO Box 724, SE-220 07 Lund Sweden Tel: +46
(0)46-19 20 00 Fax: +46 (0)46-19 11 05
Active Biotech is obligated to publish the information contained
in this press release in accordance with the Swedish Securities
Market Act and/or the Financial Instruments Trading Act. This
information was provided to the media for publication at 8:30 am
CET on April 26, 2016.
160426 Invitation AGM 2016_ENG
http://hugin.info/1002/R/2006457/741349.pdf
HUG#2006457
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Sep 2023 to Sep 2024